Literature DB >> 16898174

Anti-chromatin (anti-nucleosome) antibodies.

J A Gómez-Puerta1, R W Burlingame, R Cervera.   

Abstract

Chromatin is the native complex of histones and DNA found in the cell nucleus of eukaryotes. The fundamental subunit of chromatin is the nucleosome, which is composed of a core particle in which 146 bp of helical DNA are wrapped around an octamer made up of two H2A-H2B dimers that surround an H3-H4 tetramer. The prevalence of anti-chromatin (nucleosome) antibodies in systemic lupus erythematosus (SLE) varies from 50% to 90%, being similar to that of the classical positive LE cell. The presence of these antibodies can be used, in conjunction with clinical findings and other laboratory tests, to help in the diagnosis of SLE and drug induced lupus. The presence of anti-chromatin antibodies has also been linked to glomerulonephritis in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16898174     DOI: 10.1191/0961203306lu2325oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population.

Authors:  G A Sardeto; L M Simas; T S Skare; R M Nisihara; S R R Utiyama
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

2.  Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus.

Authors:  Adel A Shabana; Atef E El-Ghawet; Shereen A Machaly; Ekbal M Abu Hashim; Basma A El-Kady; Reham Shaat
Journal:  Clin Rheumatol       Date:  2009-03-14       Impact factor: 2.980

Review 3.  Laboratory evaluation in rheumatic diseases.

Authors:  Murat Birtane; Selçuk Yavuz; Nurettin Taştekin
Journal:  World J Methodol       Date:  2017-03-26

4.  T-bet+CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus.

Authors:  Ya Liu; Shiyu Zhou; Jie Qian; Yan Wang; Xiang Yu; Dai Dai; Min Dai; Lingling Wu; Zhuojun Liao; Zhixin Xue; Jiehua Wang; Goujun Hou; Jianyang Ma; John B Harley; Yuanjia Tang; Nan Shen
Journal:  Arthritis Res Ther       Date:  2017-10-05       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.